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Background: To meet the future challenges of infectious diseases and limit the spread of multidrug resistant
microorganisms, a better understanding of published studies in the field of infectious diseases is needed. The
objective of this study was to analyze the quantity and quality of research activity in the field of infectious diseases
in Arab countries and compare it with that in non-Arab countries.
Methods: Documents published in Arab countries within the research category of “infectious diseases” were
extracted and analyzed using the Web of Science database. The data analyzed represent research productivity
during the time interval between 1900 – 2012.
Results: Worldwide, the total number of documents published in the field of infectious diseases up to 2012 was
227,188. A total of 2,408 documents in the field of infectious diseases were published in Arab countries, which
represents 1.06% of worldwide research output. Research output from Arab countries in the field of infectious
diseases was low for decades. However, approximately a five-fold increase was observed in the past decade. Arab
countries ranked 56th to 218th on the standard competition ranking (SCR) in worldwide publications in the field of
infectious diseases. Egypt, with a total publication of 464 (19.27%) documents ranked first among Arab countries,
while Kuwait University was the most productive institution with a total of 158 (6.56%) documents. Average citation
per document published in Arab countries was 13.25 and the h-index was 64. Tuberculosis (230; 9.55%), malaria
(223; 9.26%), and hepatitis (189; 7.8%) were the top three infectious diseases studied as according to the retrieved
documents.
Conclusion: The present data reveals that some Arab countries contribute significantly to the field of infectious
diseases. However, Arab countries need to work harder to bridge the gap in this field. Compared with non-Arab
countries in the Middle East, research output from Arab countries was high, but more efforts are needed to
enhance the quality of this output. Future research in the field should be encouraged and correctly directed.
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Background
According to the Arab Union League, there are 22 inde-
pendent Arab states with more than 400 million inhabi-
tants. Poverty, inadequate health services, political
instability, and outbreaks of infectious diseases are com-
mon in many Arab countries [1-3]. For example, there
was an outbreak of polio in Syria that made international
agencies call for a ceasefire to accomplish a polio vaccin-
ation campaign [4]. Another example is the cholera out-
break in Baghdad after the second Gulf War [5]. In
Saudi Arabia, several mortalities have been attributed to
Middle East respiratory syndrome caused by the corona-
virus infection [6-8]. Furthermore, pilgrimage and other
religious seasons create a true challenge for Saudi Arabia
to prevent and control outbreaks of infectious diseases
during religious seasons [9-11]. Different types of infec-
tious diseases are prevalent and have become a health
burden for governments in many Arab countries. For ex-
ample, according to the World Health Organization
(WHO), in conservative communities that Arab coun-
tries fall into, HIV infections are rising at a faster rate,
while the coverage of antiretroviral therapy is the lowest
[12]. Furthermore, highly pathogenic and serious viral
infections such as the avian flu virus, hepatitis B, and
hepatitis C are important risks of morbidity and mortal-
ity, and pose real threats in some Arab countries such as
Egypt [13-17]. Similarly, serious parasitic infections such
as malaria, schistosomiasis, and trypanosomiasis consti-
tute a major health, social, and economic challenge in
Egypt, Sudan, Yemen, and other Arab countries [18-23].
Zoonotic infections, such as brucellosis and hydatid dis-
ease, are also present in several Arab countries and pose
a continuous health challenge [24-28]. Furthermore,
some infectious diseases such as nematode infections,
filarial infections, schistosomiasis, fascioliasis, leprosy,
and trachoma are endemic in some Arab countries and
are being neglected [29]. In addition to the abovemen-
tioned challenges pertaining to infectious diseases, there
is evidence that serious and common infectious agents
in the Arab region, such as Mycobacterium tuberculosis,
Staphylococcus aureus, and some gram-negative bacilli
are developing multiple drug resistance which is a real
future public health challenge at regional and global
levels [30-38].
To meet future challenges regarding infectious dis-
eases and limit the spread of multidrug resistant micro-
organisms in Arab countries, a better understanding of
published studies in the field of infectious diseases is
needed to have baseline data in this field so that futureresearch can be encouraged and correctly directed. No
bibliometric studies have addressed microbiological, or
parasitological or viral or infectious diseases research ac-
tivity in the Arab region. Most bibliometric studies in
Arab countries have focused on biomedical research in
general or on other medical areas [39,40]. Therefore, this
study was carried out to investigate the quantity and
quality of research activity in Arab countries in the field
of infectious diseases. This bibliometric study assessed
the past and current research activity in Arab countries
in the field of infectious diseases, in order to draw future
attention to research in this field.
Methods
The Web of Science (WoS) database was used to achieve
the objective of this study. The WoS is a trustworthy,
large, and powerful database for literature retrieval and
analysis [41]. All Arab countries: Kingdom of Saudi Arabia
(KSA), Egypt, Jordan, Lebanon, Qatar, Bahrain, Kuwait,
Morocco, Tunisia, Syrian Arab Republic (SAR), United
Arab Emirates (UAE), Iraq, Sudan, Yemen, Algeria,
Comoros, Djibouti, Libya, Mauritania, Oman, Somalia,
and Palestine, were used as the country keys, followed by
“infectious diseases,” which was used as the WoS category.
Because WoS does not recognize Palestine as an inde-
pendent state yet, search for documents about infectious
diseases from Palestine was carried out using separate
search keys in the database.
The search keys for the 21 Arab countries looked like
this: (CU = (Jordan) OR CU = (Iraq) OR CU = (Syria) OR
CU = (Saudi) OR CU = (Kuwait) OR CU = (Egypt) OR
CU = (Yemen) OR CU = (Qatar) OR CU = (Emirates) OR
CU = (Bahrain) OR CU = (Oman) OR CU = (Sudan) OR
CU = (Tunisia) OR CU = (Algeria) OR CU = (Lebanon)
OR CU = (Libya) OR CU = (Morocco) OR CU =
(Somalia) OR CU = (Djibouti) OR CU = (Comoros) OR
CU = (Mauritania)) AND WC= (infectious diseases).
The search keys for Palestine looked like this: WC= (in-
fectious diseases) AND CI = ((Nablus) OR (Jenin) OR
(Ramallah) OR (Bethlehem) OR (Tulkarm) OR (Abu Dis)
OR (Gaza)) AND CU = (Israel). The search for Palestin-
ian research output in infectious diseases was based on
the list of major Palestinian cities as a key research in
addition to the name of Israel as a country since the
WoS does not recognize Palestine as a state and con-
siders all Palestinian publications to be affiliated with
Israel.
The results from 21 Arab countries and those from
Palestine were combined and the resultant data were an-
alyzed. To increase the accuracy of the results, research
was refined and limited to original research articles and
review articles because they represent actual research ac-
tivities, while other types of documents such as edito-
rials, conference proceedings, and others were excluded.
Table 1 List of Arab countries and three non-Arab
countries in the Middle East and their Standard
Competition Ranks (SCRs) in worldwide research
productivity in the field of infectious diseases
Arab Countries Worldwide SCR*
Egypt 56
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2012. The years 2013 and 2014 were excluded in order
to enhance the accuracy of the results. If we included re-
cent years, then we might not be able to retrieve the
same number of documents if we re-do the analysis sev-
eral months later because some journal issues are re-
leased and uploaded to WoS several months after
publication online.
The WoS generates a count of the total number of ori-
ginal articles, total citations, and the value of the
h-index. Scientific output was evaluated based on a
methodology developed and used in other bibliometric
studies [42-47]. The collected data were used to generate
the following information: (a) total and trends of contri-
butions in infectious diseases research up until the speci-
fied date of December 31, 2012; (b) Arab countries
research productivity; (c) journals in which researchers
from the Arab world were published; (d) h-index for re-
trieved publications from Arab countries; and finally (e)
comparison of the results obtained from Arab countries
with those obtained from non-Arab countries such as











Data from WoS were exported to a Microsoft Office®
Excel spreadsheet and then transferred to a Microsoft
Word document. Results were converted to rank order
using the standard competition ranking (SCR). We took
into consideration the top 10 ranked publications in
each item. If the measurements of bibliometric analysis
had the same ranking number, then a gap was left in the
ranking numbers which followed. The journal’s impact
factors (IF) were evaluated using the Journal Citation
Report® (JCR; Web of Science) 2012 science edition,
published by Thomson Reuters (New York, NY, USA).*Palestine is not recognized as an independent state in the WoS database, so
rank could not be determine. Retrieval of documents from Palestine was
explained in the methodology section.Results
The total number of worldwide documents retrieved
from WoS using the methodology stated and without
specifying the name of any country was 227,188. When
the same methodology was applied using the list of Arab
countries, 2,408 documents were retrieved. Therefore,
research output from Arab countries in the field of in-
fectious diseases represents 1.06% of worldwide research
productivity. Table 1 lists the Arab countries and their
standard competition rank (SCR) worldwide. In the same
table, three non-Arab Middle Eastern countries are
shown for comparative purposes.
The top 10 journals for publication of documents in
the field of infectious diseases from Arab countries are
shown in Table 2. Approximately 8.5% of documents
from Arab countries in the field of infectious diseases
were published in journals with an IF > 5. In terms ofworldwide documents, approximately 21.5% were pub-
lished from journals with an IF > 5.
The annual number of worldwide published docu-
ments was low up until 1970. A steady and obvious in-
crease was seen after that. Growth of research in the
field of infectious diseases worldwide and from Arab
countries is shown in Figure 1. The figure presents the
data from the 1960s to 2012. Data earlier than 1960 was
excluded because the number of published documents
before 1960 was relatively low. Both worldwide and Arab
countries have shown a dramatic increase in research
productivity in infectious diseases over time. The annual
number of documents published in Arab countries indi-
cated that research output in the field remained low
until the mid-1980s and showed a great jump in the late
Table 2 Top 10 journals in which documents in the field of infectious diseases were mostly published from Arab
countries
SCRa Journal Frequency N = 2408 (%) IFb
1st Medecine et Maladies Infectieuses 202 (8.39) 0.753
2nd Bulletin de la Societe de Pathologie Exotique 138 (5.73) NA
3nd Journal of Infectious Diseases 127 (5.27) 5.848
4th International Journal of Tuberculosis and Lung Disease 115 (4.78) 2.610
5th Journal of Infection in Developing Countries 98 (4.07) 0.996
6th Emerging Infectious Diseases 80 (3.32) 5.993
7th Journal of Infection 77 (3.20) 4.073
8th Diagnostic Microbiology and Infectious Disease 73 (3.03) 2.260
9th Infection and Immunity 69 (2.87) 4.074
10th International Journal of Antimicrobial agents 67 (2.78) 4.415
10th International Journal of Infectious Diseases 67 (2.78) 2.357
Abbreviations: SCR Standard Competition Ranking, NA not available, IF impact factor.
aIf equal journals have the same ranking number, then a gap is left in the ranking numbers.
bThe impact factor was reported according to the Institute for Scientific Information (ISI) journal citation reports (JCR) 2012.
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tious diseases in Arab countries was co-authored by an
Arab researcher from Egypt in 1928 [48]. The majority
of documents retrieved from Arab countries were pub-
lished in English (2,087; 86.66%), followed by French
(311; 12.92%), and very few were published in Russian,
Spanish, and German (10; 0.42%).
When the retrieved documents were analyzed by
country, Egypt (464; 19.27%) had the highest research
output, followed by the Kingdom of Saudi Arabia (437;
18.15%) and Tunisia (365; 15.16%) (see Table 3). All
Arab countries, even those with low income and/orFigure 1 Growth of research productivity in the field of infectious disea
represents growth of research in Arab countries.political instability such as Palestine, had some contribu-
tion to the field of infectious diseases research. The most
research productive institute was Kuwait University
followed by the American University in Beirut, with 158
(6.56%) and 139 (5.78%) documents, respectively. Re-
searchers in Arab countries collaborated most with re-
searchers from the USA (475; 19.73%), France (257;
10.67%), and England (162; 6.73%).
Of the 2,408 documents considered for the h-index, 64
had been cited at least 64 times at the time of the data
analysis. Analysis of citation revealed that the Arab
country with the highest h-index was Egypt (h-index =ses. The □ line represents worldwide growth while the▼ line
Table 3 Research productivity of Arab and three non-Arab countries in the field of infectious diseases, including the
h-index and mean citation per document
Arab country Frequency N = 2408 (%) h-index Mean citation per document
Egypt 464 (19.27) 41 16.08
Kingdom of Saudi Arabia 437 (18.15) 36 15.64
Tunisia 365 (15.16) 25 8.89
Morocco 216 (8.97) 22 9.96
Kuwait 175 (7.27) 27 17.61
Lebanon 173 (7.18) 24 14.14
Sudan 165 (6.85) 28 16.28
Algeria 134 (5.57) 16 8.06
United Arab Emirates 128 (5.32) 27 19.98
Jordan 79 (3.28) 16 12.81
Qatar 55 (2.28) 11 7.58
Bahrain 44 (1.83) 11 9.82
Oman 34 (1.41) 9 8.47
Iraq 29 (1.20) 8 11.03
Syria 29 (1.20) 10 8.21
Yemen 23 (0.96) 6 5.62
Libya 22 (0.91) 8 9.64
Mauritania 19 (0.79) 8 10.00
Palestine 11 (0.46) 4 4.91
Somalia 6 (0.25) 4 12.33
Comoros 6 (0.25) 4 5.17
Djibouti 5 (0.21) 4 8.00
Non-Arab Countries versus 22 Arab Countries
“non-Arab countries” 2,408 64 13.25
Israel 2,095 93 24.11
Turkey 1,461 53 12.77
Iran 572 29 9.04
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per document was the United Arab Emirates (20 cita-
tions per document). Compared with other non-Arab
countries in the Middle East, the research output from
Arab countries was higher than that from Israel, Turkey,
and Iran. However, the quality of research output from
Arab countries, measured as h-index, was less than that
from Israel but higher than that from Turkey or Iran
(see Table 3). The top infectious diseases studied as per
the retrieved published documents were: tuberculosis
(230; 9.55%), malaria (223; 9.26%), hepatitis (189; 7.8%),
HIV (186; 7.72%), diarrhea/gastroenteritis (150; 6.23%),
meningitis (115; 4.78%), leishmaniasis (111; 4.6%), sal-
monella (92; 3.82%), and influenza (52; 2.16%).
Discussion
In this study, we assessed research productivity in the
field of infectious diseases in Arab countries. Our resultsindicated that there is an obvious and promising rise in
research activity in Arab countries in this field. However,
none of the Arab countries ranked among the first 50
countries in terms of worldwide contribution to research
output in this field. This was disappointing given that
three non-Arab Middle Eastern countries—Israel, Iran,
and Turkey—were ranked among the first top 50 coun-
tries. Among the Arab countries, Egypt and KSA occu-
pied the top rank. Large populations and high national
incomes are the most probable reasons for this. Com-
pared with non-Arab countries in the Middle East, the
number of published research documents in Arab coun-
tries was the highest. However, the quality of the pub-
lished documents in Arab countries, as measured by the
h-index and/or average citation per document, was
lesser than that from Israel possibly because of the rela-
tively low impact factor (IF) of journals in which the
bulk of the documents from Arab countries were
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quality [49]. The h-index was developed to overcome
the main disadvantages of other bibliometric indicators,
such as total number of papers or total number of cita-
tions. The h-index simultaneously measures the quality
and quantity of scientific output, and is one of the most
commonly used indicators of research quality. However,
if the h-index is used to measure documents from differ-
ent databases, then this can give different values. There-
fore, each database has pros and cons when being
measured by the h-index [50-52]. Criticisms have also
been addressed to the use of the h-index as a marker of
publication quality and citation. For example, the h-
index does not consider the context of citations or the
number of authors in the document, and gives equal
values for book citation and research citations. There-
fore, the h-index has a lesser predictive accuracy and
precision than measuring using mean citations per
paper, although this is controversial [53,54].
Infectious diseases have no borders and prevention;
control and eradication of infectious diseases requires
worldwide efforts. Arab countries have been the source
of some fatal infectious diseases, and they should heavily
participate and cooperate in research in order to combat
them [55-58]. For example, the Middle East respiratory
syndrome was initially diagnosed in KSA but reports of
cases in distant parts of the world have been identified
due to people traveling from KSA [59-62]. Several re-
search documents about serious infectious agents such
as the West Nile Virus have been published in the USA
and Europe through cooperation with Arab institutions
and investigators [63,64]. Arab countries should also
cooperate in research regarding resistant cases of infec-
tious agents particularly those pertaining to Mycobacter-
ium tuberculosis. Emergence of resistant strains causing
tuberculosis is a challenge for many developing coun-
tries [65]. Another important example of an infectious
disease common in Arab countries that has been investi-
gated through several cooperative research studies is
leishmaniasis [66-68]. Cooperation in research becomes
evident when we compare research interests of Arab in-
vestigators with those in other countries. Research col-
laboration improves the quality and quantity of research
output, as well as the visibility of national health prob-
lems [69-72]. Furthermore, international collaboration in
research helps in capacity building in developing coun-
tries and makes national problems of developing coun-
tries more observable [73]. Arab researchers need to
take the lead and promote research projects in the field
of infectious diseases as an important public health con-
cern. Obstacles to do research such as inadequate fund-
ing, an unstable democratic atmosphere, and an unclear
national policy toward health research are, unfortu-
nately, prevalent in Arab countries. Everyone shouldparticipate in the war against infectious diseases includ-
ing clerks and politicians who can help in the fight of in-
fectious diseases such as HIV/AIDS [74,75]. Researchers,
academics, and healthcare professionals should promote
vaccinations against infectious diseases as well as public
hygiene as a methods of early prevention [76,77]. Re-
search output from a particular country is not only a
point of prestige but also a reflection of the care of gov-
ernments toward citizens and their individual health. Of
course, the research activity and capacity of a particular
country depends on several factors including the na-
tional income and the size of the population. However,
in the case of infectious diseases, Arab countries, with a
population of over 400 million and huge resources, must
strive for excellence in research pertaining to infectious
diseases. In addition, Arab countries need to invest in
research in infectious diseases to limit the spread of mi-
crobial drug resistance that might be unique in different
world regions. To achieve this, Arab countries must in-
vest more in research activity in the field of infectious
diseases.
Our study is the first to analyze the quantity and qual-
ity of research productivity in the field of infectious dis-
eases in Arab countries. The database used for analysis,
Web of Science (WoS), is one of the most trustworthy
databases that allows for powerful citation analysis. It is
well known that the most leading and influential jour-
nals in the field of medicine and health are indexed in
WoS. However, articles published in non-WoS indexed
journals were not included in the analysis. Despite this,
the aim of this paper was to initiate discussion among
professionals and academics pertaining to infectious dis-
eases research activity in Arab countries rather than
criticize or praise the research activity itself.
Conclusion
Our study showed that research in the field of infectious
diseases is rising in some Arab countries such as Egypt
and KSA, and that more efforts are required to bridge
the gap with some of the other countries. Research col-
laboration between institutions in Arab countries with
international researchers and institutions in the field of
infectious diseases should be sought. Governmental
funding and support for infectious diseases research is
also recommended.
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